Trial intelligence / Profile preview

Sabin IPV and bOPV Sequential Immunization in Chinese Infants

NCT03147560Phase 4Completed

Start
May 2017
Primary completion
Dec 2017
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Inactivated poliovirus vaccine (Sabin strain) and bivalent oral poliovirus vaccine in poliomyelitis. Primary endpoint: Seroconversion rate. Started May 2017; status: completed.

02

Drugs

Inactivated poliovirus vaccine (Sabin strain)bivalent oral poliovirus vaccine
03

Conditions

poliomyelitis

Beyond the preview

Go deeper on NCT03147560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03147560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call